Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Stemline Therapeutics Inc (NASDAQ:STML)

4.26
Delayed Data
As of Feb 11
 +0.15 / +3.65%
Today’s Change
4.02
Today|||52-Week Range
17.40
-32.49%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Hoberman Kenneth
Chief Operating Officer
Sale3/19/201517,307$16.43$284.4K-73.67%
Hoberman Kenneth
Chief Operating Officer
Buy3/19/201527,105$4.09$110.9K-73.67%
Bergstein Ivan
Chief Executive Officer
Sale11/30/201512,235$8.20$100.3K-48.30%
Bergstein Ivan
Chief Executive Officer
Sale2/18/20153,180$14.02$44.6K-69.74%
Rowinsky Eric K
Chief Medical Officer
Sale2/18/20151,640$13.99$22.9K-69.74%
Bentsur Ronald
Director
Sale3/18/20151,388$16.12$22.4K-73.26%
Hoberman Kenneth
Chief Operating Officer
Sale2/18/20151,593$14.02$22.3K-69.74%
Bentsur Ronald
Director
Buy3/18/20155,421$4.09$22.2K-73.26%
Gionco David G
Chief Accounting Officer
Sale1/19/20163,171$4.82$15.3K-11.43%
Gionco David G
Chief Accounting Officer
Sale1/20/201646$4.69$215.74-15.31%
Page of 3